Wealth Trak Capital Management LLC Denali Therapeutics Inc. Transaction History
Wealth Trak Capital Management LLC
- $118 Billion
- Q4 2024
A detailed history of Wealth Trak Capital Management LLC transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, Wealth Trak Capital Management LLC holds 10 shares of DNLI stock, worth $145. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10Holding current value
$145% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding DNLI
# of Institutions
240Shares Held
121MCall Options Held
80KPut Options Held
36.8K-
Black Rock Inc. New York, NY13.2MShares$191 Million0.01% of portfolio
-
Baillie Gifford & CO12.3MShares$179 Million0.2% of portfolio
-
Vanguard Group Inc Valley Forge, PA12MShares$174 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA9.85MShares$143 Million0.04% of portfolio
-
Capital Research Global Investors Los Angeles, CA5.48MShares$79.5 Million0.02% of portfolio
About Denali Therapeutics Inc.
- Ticker DNLI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 134,174,000
- Market Cap $1.95B
- Description
- Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...